BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36595939)

  • 1. Protocol to analyze dysregulation of the eIF4F complex in human cancers using R software and large public datasets.
    Wu S; Wagner G
    STAR Protoc; 2022 Dec; 3(4):101880. PubMed ID: 36595939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep computational analysis details dysregulation of eukaryotic translation initiation complex eIF4F in human cancers.
    Wu S; Wagner G
    Cell Syst; 2021 Sep; 12(9):907-923.e6. PubMed ID: 34358439
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Shen S; Girault I; Malka-Mahieu H; Robert C; Vagner S
    STAR Protoc; 2021 Sep; 2(3):100621. PubMed ID: 34223196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells.
    Frosi Y; Ramlan SR; Brown CJ
    J Vis Exp; 2020 May; (159):. PubMed ID: 32421011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging therapeutics targeting mRNA translation.
    Malina A; Mills JR; Pelletier J
    Cold Spring Harb Perspect Biol; 2012 Apr; 4(4):a012377. PubMed ID: 22474009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsic RNA binding by the eukaryotic initiation factor 4F depends on a minimal RNA length but not on the m7G cap.
    Kaye NM; Emmett KJ; Merrick WC; Jankowsky E
    J Biol Chem; 2009 Jun; 284(26):17742-50. PubMed ID: 19414591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic changes in eIF4F-mRNA interactions revealed by global analyses of environmental stress responses.
    Costello JL; Kershaw CJ; Castelli LM; Talavera D; Rowe W; Sims PFG; Ashe MP; Grant CM; Hubbard SJ; Pavitt GD
    Genome Biol; 2017 Oct; 18(1):201. PubMed ID: 29078784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mRNA- and factor-driven dynamic variability controls eIF4F-cap recognition for translation initiation.
    Çetin B; O'Leary SE
    Nucleic Acids Res; 2022 Aug; 50(14):8240-8261. PubMed ID: 35871304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron enhances the binding rates and translational efficiency of iron responsive elements (IREs) mRNA with initiation factor eIF4F.
    Khan MA; Domashevskiy AV
    PLoS One; 2021; 16(4):e0250374. PubMed ID: 33882101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cap-dependent mRNA translation and the ubiquitin-proteasome system cooperate to promote ERBB2-dependent esophageal cancer phenotype.
    Issaenko OA; Bitterman PB; Polunovsky VA; Dahlberg PS
    Cancer Gene Ther; 2012 Sep; 19(9):609-18. PubMed ID: 22767218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cap for Every Occasion: Alternative eIF4F Complexes.
    Ho JJD; Lee S
    Trends Biochem Sci; 2016 Oct; 41(10):821-823. PubMed ID: 27283511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for variation in the optimal translation initiation complex: plant eIF4B, eIF4F, and eIF(iso)4F differentially promote translation of mRNAs.
    Mayberry LK; Allen ML; Dennis MD; Browning KS
    Plant Physiol; 2009 Aug; 150(4):1844-54. PubMed ID: 19493973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies.
    Boussemart L; Malka-Mahieu H; Girault I; Allard D; Hemmingsson O; Tomasic G; Thomas M; Basmadjian C; Ribeiro N; Thuaud F; Mateus C; Routier E; Kamsu-Kom N; Agoussi S; Eggermont AM; Désaubry L; Robert C; Vagner S
    Nature; 2014 Sep; 513(7516):105-9. PubMed ID: 25079330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the eIF4F translation initiation complex: a critical nexus for cancer development.
    Pelletier J; Graff J; Ruggero D; Sonenberg N
    Cancer Res; 2015 Jan; 75(2):250-63. PubMed ID: 25593033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. m
    Coots RA; Liu XM; Mao Y; Dong L; Zhou J; Wan J; Zhang X; Qian SB
    Mol Cell; 2017 Nov; 68(3):504-514.e7. PubMed ID: 29107534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the eIF4F translation initiation complex for cancer therapy.
    Konicek BW; Dumstorf CA; Graff JR
    Cell Cycle; 2008 Aug; 7(16):2466-71. PubMed ID: 18719377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Pathways: The eIF4F Translation Initiation Complex-New Opportunities for Cancer Treatment.
    Malka-Mahieu H; Newman M; Désaubry L; Robert C; Vagner S
    Clin Cancer Res; 2017 Jan; 23(1):21-25. PubMed ID: 27789529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translational control of cell fate: from integration of environmental signals to breaching anticancer defense.
    Bitterman PB; Polunovsky VA
    Cell Cycle; 2012 Mar; 11(6):1097-107. PubMed ID: 22356766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eukaryotic initiation factor (eIF) 4F binding to barley yellow dwarf virus (BYDV) 3'-untranslated region correlates with translation efficiency.
    Banerjee B; Goss DJ
    J Biol Chem; 2014 Feb; 289(7):4286-94. PubMed ID: 24379412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translating from cancer to the brain: regulation of protein synthesis by eIF4F.
    Kats IR; Klann E
    Learn Mem; 2019 Sep; 26(9):332-342. PubMed ID: 31416906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.